TILT Biotherapeutics
TILT Biotherapeutics is a developer of gene therapies for cancer founded in 2013 by Akseli Hemminki.
3
Funding Rounds
$47.6m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ak**** He****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company TILT Biotherapeutics has raised a total of $47.6m in funding over 3 rounds.
Key Insights:
- TILT Biotherapeutics Series B Round, May 2025: $25.6m
- TILT Biotherapeutics February 2023 Series A Funding Round: $11m
- TILT Biotherapeutics December 2016 Seed Funding Round: $11m
TILT Biotherapeutics Series B Round, May 2025
$25.6m
TILT Biotherapeutics February 2023 Series A Funding Round
$11m
TILT Biotherapeutics December 2016 Seed Funding Round
$11m
Industries
TILT Biotherapeutics is active in the following industries: